Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhalational Ethanol Therapy in COVID-19
NCT05268419Phase 3Completed
- Start
- Sep 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of gelified ethanol in coronavirus disease 2019 (COVID-19) (2 arms). Primary endpoint: Global Symptomatic Score at day 14. Started Sep 2021; status: completed.
02
Drugs
gelified ethanol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05268419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05268419.